Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4-day, Open-Label, Multicenter Phase 3b Study of IV YM087 in Patients With Euvolemic or Hypervolemic Hyponatremia

NCT00379847 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.

NCT NCT00379847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00379847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4-day, Open-Label, Multicenter Phase 3b Study of IV YM087 in Patients With Euvolemic or Hypervolemic Hyponatremia
Lead sponsor
Cumberland Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
June 30, 2005
Enrollment
251 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

hyponatremia